6505--nuclear medicine radiopharmaceuticals

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 seeks supply of nuclear medicine radiopharmaceuticals for the Cheyenne VA Medical Center, with proposals due May 18, 2026 at 12:00 PM Mountain Time. This is not a set-aside contract; the PSC is 6505 (Radiopharmaceuticals and Related Supplies) and NAICS is 325412 (Pharmaceutical Preparation Manufacturing).

The contract vehicle is a five-year Indefinite Delivery Contract running from June 1, 2026 through May 31, 2031, comprising a base ordering period through May 31, 2027 and four additional one-year options. Place of performance is the Cheyenne VA Medical Center, 2360 E Pershing Blvd, Cheyenne, Wyoming, with administrative oversight at the Network Contracting Office in Greenwood Village, Colorado.

The scope includes a minimum of 25 line items spanning multiple radiopharmaceutical products: Xe-133 20mCi vials (standing order basis, weekly), Technetium-99m Non-HEU formulations (Sodium Pertechnetate, Sestamibi, Medronate, Mebrofenin, Sulfur Colloid, Pyrophosphate), I-123 capsules, Co-57 sheet sources, and related supplies including syringe shields, xenon vent kits, delivery charges, and survey meter calibration services. Estimated annual quantities range from 2 units for Co-57 sheet sources and calibration services to 1,000 units for Sestamibi Tc-99m. All products and services must comply with NRC regulations, DOT hazardous materials standards, USP specifications, state radiation control statutes, VA Radiation Safety Policies, and FDA regulations. The contractor must maintain emergency response procedures for same-day deliveries and report NRC-reportable events. Unit pricing has not yet been established. The Contracting Officer is Barron Long at barron.long@va.gov.